| RS2508552605 |
B9D1
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS2508566475 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS2508567532 |
RAI1
|
Health Risk |
Pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS2508567631 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2508567726 |
RAI1
|
Health Risk |
Pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS2508567901 |
RAI1
|
Health Risk |
Likely pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS2508568958 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS2508569038 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS2508569046 |
MYH3
|
Health Risk |
Pathogenic |
— |
| RS2508569160 |
RAI1
|
Health Risk |
Likely pathogenic |
RAI1-related disorder, RAI1-related disorder |
| RS2508569771 |
RAI1
|
Health Risk |
Likely pathogenic |
Syndromic intellectual disability, Syndromic intellectual disability |
| RS2508569976 |
RAI1
|
Health Risk |
Likely pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS2508570088 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS2508571561 |
RAI1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS2508571701 |
MYH3
|
Health Risk |
Pathogenic |
— |
| RS2508572032 |
RAI1
|
Health Risk |
Pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS2508572124 |
IFT140
|
Health Risk |
Pathogenic/Likely pathogenic |
Retinitis pigmentosa 80, Saldino-Mainzer syndrome |
| RS2508572127 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS2508572306 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2508572820 |
IFT140
|
Health Risk |
Pathogenic |
Saldino-Mainzer syndrome, Saldino-Mainzer syndrome |
| RS2508572957 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS2508575839 |
RAI1
|
Health Risk |
Pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS2508577262 |
RAI1
|
Health Risk |
Likely pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS2508577352 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS2508577759 |
MYH3
|
Health Risk |
Likely pathogenic |
Spondylocarpotarsal synostosis syndrome, Spondylocarpotarsal synostosis syndrome |
| RS2508577969 |
RAI1
|
Health Risk |
Pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS2508578544 |
MYH3
|
Health Risk |
Likely pathogenic |
MYH3-related disorder, MYH3-related disorder |
| RS2508580281 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS2508580813 |
RAI1
|
Health Risk |
Pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS2508581126 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS2508581992 |
RAI1
|
Health Risk |
Likely pathogenic |
RAI1-related disorder, RAI1-related disorder |
| RS2508583396 |
RAI1
|
Health Risk |
Pathogenic/Likely pathogenic |
Inborn genetic diseases, Smith-Magenis syndrome |
| RS2508583461 |
RAI1
|
Health Risk |
Pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS2508583911 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS2508585255 |
RAI1
|
Health Risk |
Likely pathogenic |
RAI1-related disorder, RAI1-related disorder |
| RS2508586127 |
RAI1
|
Health Risk |
Pathogenic |
— |
| RS2508586323 |
RAI1
|
Health Risk |
Likely pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS2508587478 |
RAI1
|
Health Risk |
Likely pathogenic |
Smith-Magenis syndrome, Smith-Magenis syndrome |
| RS2508592574 |
MYH3
|
Health Risk |
Pathogenic |
— |
| RS2508595763 |
MYH3
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS2508595899 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial meningioma, Hereditary cancer-predisposing syndrome |
| RS2508595907 |
SMARCE1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2508596024 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial meningioma |
| RS2508596385 |
MYH3
|
Health Risk |
Likely pathogenic |
— |
| RS2508596395 |
MYH3
|
Health Risk |
Likely pathogenic |
Freeman-Sheldon syndrome, Freeman-Sheldon syndrome |
| RS2508597255 |
SMARCE1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2508597454 |
SMARCE1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial meningioma |
| RS2508598327 |
SMARCE1
|
Health Risk |
Likely pathogenic |
Familial meningioma, Familial meningioma |
| RS2508598488 |
SMARCE1
|
Health Risk |
Pathogenic |
Familial meningioma, Familial meningioma |
| RS2508598492 |
SMARCE1
|
Health Risk |
Likely pathogenic |
Familial meningioma, Familial meningioma |
| RS2508598549 |
SMARCE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Familial meningioma |
| RS2508599743 |
FANCI
|
Health Risk |
Likely pathogenic |
Fanconi anemia complementation group I, Fanconi anemia complementation group I |
| RS2508601282 |
MYH3
|
Health Risk |
Likely pathogenic |
MYH3-related disorder, MYH3-related disorder |
| RS2508603360 |
MYH3
|
Health Risk |
Likely pathogenic |
— |
| RS2508603561 |
SMARCE1
|
Health Risk |
Pathogenic |
Familial meningioma, Familial meningioma |
| RS2508603762 |
SMARCE1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2508603823 |
SMARCE1
|
Health Risk |
Pathogenic |
Familial meningioma, Familial meningioma |
| RS2508604668 |
SMARCE1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial meningioma |
| RS2508604703 |
SMARCE1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2508604717 |
SMARCE1
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS2508605867 |
MYH3
|
Health Risk |
Likely pathogenic |
Freeman-Sheldon syndrome, Freeman-Sheldon syndrome |
| RS2508612985 |
MYH3
|
Health Risk |
Likely pathogenic |
— |
| RS2508613715 |
MYH3
|
Health Risk |
Likely pathogenic |
MYH3-related disorder, MYH3-related disorder |
| RS2508614011 |
MYH3
|
Health Risk |
Likely pathogenic |
— |
| RS2508620380 |
MYH3
|
Health Risk |
Pathogenic |
— |
| RS2508621465 |
MYH3
|
Health Risk |
Pathogenic |
— |
| RS2508627354 |
MYH3
|
Health Risk |
Pathogenic |
— |
| RS2508630786 |
MYH3
|
Health Risk |
Pathogenic |
— |
| RS2508635033 |
MYH3
|
Health Risk |
Likely pathogenic |
Arthrogryposis, distal |
| RS2508637956 |
MYH3
|
Health Risk |
Likely pathogenic |
— |
| RS2508638061 |
MYH3
|
Health Risk |
Pathogenic |
— |
| RS2508639104 |
PARN
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 6 |
| RS2508640323 |
PARN
|
Health Risk |
Pathogenic |
Dyskeratosis congenita, autosomal recessive 6 |
| RS2508643762 |
MYH3
|
Health Risk |
Pathogenic |
— |
| RS2508657357 |
EIF5A
|
Health Risk |
Likely pathogenic |
— |
| RS2508658475 |
PARN
|
Health Risk |
Likely pathogenic |
Dyskeratosis congenita, autosomal recessive 6 |
| RS2508661900 |
SUZ12
|
Health Risk |
Likely pathogenic |
Imagawa-Matsumoto syndrome, Imagawa-Matsumoto syndrome |
| RS2508662320 |
SUZ12
|
Health Risk |
Likely pathogenic |
Imagawa-Matsumoto syndrome, Imagawa-Matsumoto syndrome |
| RS2508673713 |
EIF5A
|
Health Risk |
Likely pathogenic |
Faundes-Banka syndrome, Faundes-Banka syndrome |
| RS2508674028 |
EIF5A
|
Health Risk |
Likely pathogenic |
— |
| RS2508675963 |
EIF5A
|
Health Risk |
Likely pathogenic |
— |
| RS2508677290 |
SUZ12
|
Health Risk |
Likely pathogenic |
Imagawa-Matsumoto syndrome, Imagawa-Matsumoto syndrome |
| RS2508684640 |
SUZ12
|
Health Risk |
Likely pathogenic |
Imagawa-Matsumoto syndrome, Imagawa-Matsumoto syndrome |
| RS2508693927 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508694092 |
NF1
|
Health Risk |
Pathogenic |
Cardiovascular phenotype, Hereditary cancer-predisposing syndrome |
| RS2508694271 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508694321 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508694334 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508694361 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508694473 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508694547 |
NF1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurofibromatosis-Noonan syndrome, Neurofibromatosis |
| RS2508694660 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508694786 |
NF1
|
Health Risk |
Pathogenic |
NF1-related disorder, NF1-related disorder |
| RS2508694797 |
NF1
|
Health Risk |
Likely pathogenic |
Juvenile myelomonocytic leukemia, Juvenile myelomonocytic leukemia |
| RS2508694806 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508694851 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508694884 |
NF1
|
Health Risk |
Likely pathogenic |
Neurofibromatosis, type 1 |
| RS2508694932 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508695004 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |
| RS2508695148 |
NF1
|
Health Risk |
Pathogenic |
Neurofibromatosis, type 1 |